Cargando…
Evaluation of Sexual Dimorphism in the Efficacy and Safety of Simvastatin/Atorvastatin Therapy in a Southern Brazilian Cohort
BACKGROUND: Dyslipidemia is the primary risk factor for cardiovascular disease, and statins have been effective in controlling lipid levels. Sex differences in the pharmacokinetics and pharmacodynamics of statins contribute to interindividual variations in drug efficacy and toxicity. OBJECTIVE: To e...
Autores principales: | Smiderle, Lisiane, Lima, Luciana O., Hutz, Mara Helena, der Sand, Cézar Roberto Van, der Sand, Luiz Carlos Van, Ferreira, Maria Elvira Wagner, Pires, Renan Canibal, Almeida, Silvana, Fiegenbaum, Marilu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cardiologia
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126759/ https://www.ncbi.nlm.nih.gov/pubmed/25120083 http://dx.doi.org/10.5935/abc.20140085 |
Ejemplares similares
-
The lactase persistence genotype is a protective factor for the metabolic syndrome
por: Friedrich, Deise C., et al.
Publicado: (2014) -
Atorvastatin and simvastatin protects cognitive impairment in an animal model of sepsis
por: Alexandre, Pedro CB, et al.
Publicado: (2013) -
Atorvastatin and simvastatin as analgesic agents in experimental models
por: Dwajani, S., et al.
Publicado: (2012) -
Blood groups in Native Americans: a look beyond ABO and
Rh
por: Rodrigues, Mirelen Moura de Oliveira, et al.
Publicado: (2021) -
Experimental evaluation of analgesic and anti-inflammatory activity of simvastatin and atorvastatin
por: Jaiswal, Swapnil R., et al.
Publicado: (2012)